Updates

Date: 10th July 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street, Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001 Scrip Symbol- SUDEEPPHRM Scrip Code: 544619 Sub: Letter to Shareholders Ref: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (‘Listing Regulations’) Dear Sir/Madam, Pursuant to Regulation 36(1)(b) of SEBI (LODR) Regulations 2015 the Company has sent a letter providing a web-link of the Integrated Annual Report for the FY 2025-26 to those Members who have not registered their e-mail addresses with the Company/Depositories. A copy of the letter is enclosed for your record. The above information is also uploaded on the Company’s website viz. https://www.sudeeppharma.com/ Kindly take note of the same. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com Date: 10th July 2026 Dear Shareholders Sub: Web-link of the Notice of 37th Annual General Meeting of the Members of Sudeep Pharma Limited and Integrated Annual Report for the Financial Year 2025-26 We are pleased to inform you that the 37th Annual General Meeting (“AGM”) of Sudeep Pharma Limited (‘the Company’) is scheduled to be held on Tuesday, 4th August 2026 at 11:00 a.m. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) in compliance with the various circulars issued by MCA and SEBI from time to time. The Notice of the 37th AGM along with the Integrated Annual Report for the Financial Year 2025-26 is being sent by electronic mode to the members whose e-mail addresses are registered with the Company’s Registrar & Share Transfer Agent (RTA) / Depositories/Depository Participants (DPs). Further, in compliance with Regulation 36(1) of the SEBI (LODR) Regulations, 2015 (‘SEBI Listing Regulations’), the Company is sending individual letters providing the web-link, including the exact path, where complete details of the Integrated Report along with the Notice can be accessed, to those shareholders whose e-mail addresses are not registered with the Company/RTA/Depositories/DPs. We wish to inform you that, on scrutiny of the shareholder’s database, we find that your e-mail address is not registered against your Demat Account No./Folio No. Hence, this letter is being sent by the Company to inform you that: 1. The link to access the Integrated Report is https://www.sudeeppharma.com/wp-content/uploads/2026/07/Annual-Report-FY- 2025-26.pdf 2. The link to access the AGM Notice is https://www.sudeeppharma.com/wp-content/uploads/2026/07/Notice-of-AGM-FY-2025- 26.pdf Key details of the AGM are as follows: Sr. No. Particulars Day and Date 1. Last date for submission of TDS exemption forms Wednesday, 22nd July, 2026 2. Record date for Final Dividend Thursday, 23rd July, 2026 3. Cut-off date for Remote e-Voting Tuesday, 28th July, 2026 4. Remote e-Voting start date and time Saturday, 1st August, 2026 at 09:00 A.M. 5. Remote e-Voting end date and time Up Monday, 3rd August, 2026 at 05:00 P.M. 6. Dividend payment date Friday, 7th August 2026 For more details, please refer to the ‘Notes’ section to the Notice of AGM. You are requested to update and complete your KYC* details with: • Depository Participants (DPs), if shares held in electronic form. • Company / Registrar and Transfer Agent ("RTA") through Service request, if shares held in physical form. *(including name, postal address, email ID, telephone/mobile numbers, PAN, mandates, nominations, power of attorney and Bank Details) Email id to submit the tax exemption forms cs.sudeep@sudeepgroup.com or dimple.mehta@sudeepgroup.com For detailed procedure for remote e-voting / e-voting Please refer to pages 42 to 47 of the Integrated Annual Report and attending AGM through VC/OAVM All the work related to share registry in terms of electronic, is being carried out by the Company’s Registrar & Share Transfer Agent (“RTA”) – MUFG Intime India Private Limited at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai – 400 083, Maharashtra, India. Tel No +91 22 4918 6000. Email: Csgexemptforms2627@in.mpms.mufg.com” The shareholders are requested to send their communication to the aforesaid address, quoting their Folio No/DP ID no and name of Company. Thanking You, For Sudeep Pharma Limited Sd/- Dimple Mehta Company Secretary & Compliance Officer M. No. F13184 CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com